Karin Barbin

Effective lysis of lymphoma cells with a stabilised bispecific single‐chain Fv antibody against CD19 and Fc<i>γ</i>RIII (CD16)

Joerg Bruenke, Karin Barbin, Susanne Kunert et al. · British Journal of Haematology · 2005 · 59 citations · Full text

Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell–depleted allografts

Peter Lang, Karin Barbin, Tobias Feuchtinger et al. · Blood · 2004 · 54 citations · Full text

Cell Therapy, Immunology, Cd4 T Cell Responses +19

A recombinant bispecific single‐chain Fv antibody against HLA class II and FcγRIII (CD16) triggers effective lysis of lymphoma cells

Joerg Bruenke, Barbara Fischer, Karin Barbin et al. · British Journal of Haematology · 2004 · 50 citations · Full text

A CD33‐specific single‐chain immunotoxin mediates potent apoptosis of cultured human myeloid leukaemia cells

Michael Schwemmlein, Matthias Peipp, Karin Barbin et al. · British Journal of Haematology · 2006 · 45 citations · Full text

Heterodimeric bispecific antibody-derivatives against CD19 and CD16 induce effective antibody-dependent cellular cytotoxicity against B-lymphoid tumor cells

Christian Kellner, Joerg Bruenke, Heike Horner et al. · Cancer Letters · 2011 · 44 citations

Immunology, Immune Checkpoint Inhibitor, Autoimmunity +6